Vascular Biogenics L
VBLT
Delayed Nasdaq - 02/22 07:23:51 pm
6.7USD
+3.08%
Upcoming events
03/27/18
FY 2017 Earnings Release (Projected)
Past Events
11/28/17 | 08:30pmPiper Jaffray Health Care Conference
11/14/17 | 02:30pmQ3 2017 Earnings Call
11/14/17Q3 2017 Earnings Release
10/10/17 | 07:45pmChardan Gene Therapy Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread



10,0
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-16,3
-14,8
-9,8%

-23,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-16,0
-14,6
-9,4%

-8,12
Net income
Million $
Released
Forecast
Spread
-16,0
-14,6
-9,4%

-13,1
EPS
 $
Released
Forecast
Spread
-0,64
-0,59
-9,4%

-0,49
Announcement Date03/27/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread



5,00
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-6,48
-5,05
-28%

-6,94
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-6,54
-4,76
-37%

0,98
Net income
Million $
Released
Forecast
Spread
-6,54
-4,76
-37%

-1,52
EPS
 $
Released
Forecast
Spread
-0,24
-0,18
-36%

-0,06
Announcement Date11/14/2017
Operating profit - Rate of surprise
EPS - Rate of surprise